Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer
The underlying molecular heterogeneity of cancer is responsible for the dynamic clinical landscape of this disease. The combination of genomic and proteomic alterations, including both inherited and acquired mutations, promotes tumor diversity and accounts for variable disease progression, therapeut...
Main Authors: | Christen A. Khella, Gaurav A. Mehta, Rushabh N. Mehta, Michael L. Gatza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/2/149 |
Similar Items
-
Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis
by: Miaomiao Ye, et al.
Published: (2021-09-01) -
‘Omics Approaches to Explore the Breast Cancer Landscape
by: Joseph Parsons, et al.
Published: (2020-01-01) -
Advances in Epigenetics and Integration of Omics in Lupus
by: Joyce S. Hui-Yuen, et al.
Published: (2017-08-01) -
Molecular Genetics of Breast and Ovarian Cancer: Recent Advances and Clinical Implications
by: Dörk Thilo, et al.
Published: (2012-12-01) -
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
by: Ana Alcaraz-Sanabria, et al.
Published: (2020-01-01)